Announcing the New Early Career Research & Publications Network

Announcing the New Early Career Research & Publications Network

IGCS Members & Friends,

As recently communicated by our President, Roberto Angioli, IGCS is forming an Early Career Research & Publications Network to provide our members, who are early in their careers with a support system consisting of peers and mentors to discuss research, publishing and writing. The network will also afford members the opportunity to develop and promote research projects either individually or with colleagues who share mutual interests.

I am excited to have three volunteer mentors to help me with the network. They are very experienced in career development, mentorship, publishing and scientific presentations. These individuals will regularly communicate with members of the network to stimulate research ideas, provoke and moderate discussions, and facilitate collaborations within the network via zoom (video) teleconferences.

Elena Ioana Braicu, MD, PhD
Charité Universitätsmedizin Berlin – Germany
Network Mentor

Sean Dowdy, MD
Mayo Clinic Rochester, MN
United States
Network Mentor
Francesco Plotti, MD, PhD
Università Campus Bio-Medico di Roma – Italy
Network Mentor

This network is open to IGCS members who are dedicated to the care of women with gynecologic cancers and are within the first five years of practice following completion of their training. It will convene via video conference, online discussion boards and in-person meetings at the IGCS Annual Global Meeting.

Eligible early career members may request to join the network by completing this brief online form. Nonmembers who are interested should first become a member of the IGCS, then request to join the network. Questions or comments regarding the network may be directed to the IGCS Membership Manager, Cathy Fearing at cathy.fearing@igcs.org.

On behalf of the IGCS leadership, we are thrilled to offer this networking opportunity to our early career members. I truly believe mentorship and collaboration among peers will aid in the development of our young members and facilitate new research to improve women’s cancer care worldwide. This is a true investment in our future.

 

I look forward to receiving the completed forms and kicking off our network in the coming months.

Robert Coleman, MD
IGCS President-Elect

Welcome Malaysia, Peru & the Caribbean!

IGCS welcomes three societies bringing a total of 127 new members to the Strategic Alliance Partnership Program:

The Caribbean
The Caribbean Gynecologic Cancer Society (CGCS) has joined the IGCS Strategic Alliance Partner bringing 43 Caribbean members to our international community. Dr. Raleigh Butler, the Program Director of the Gynecologic Oncology Fellowship at the University of the West Indies Bahamas led the charge in securing this partnership. CGCS was founded in 2015 and is made up of physicians specializing in gynecologic oncology from the University of the West Indies (UWI) campuses of Jamaica, Trinidad, Barbados and Bahamas.
With different cultures, governments, political histories and populations, the standards of medical facilities can vary from island to island. Recent research revealed that the Bahamas has the highest occurrence of BRCA-positivity in the world. Cervical cancer incidence is 22.1 per 100,000 in the UWI campus countries combined.

Acknowledging that the region had a wealth of talented individuals who had trained at home and overseas, the UWI campuses initiated a collaborative approach to fighting gynecological malignancies across the region. The IGCS Global Curriculum and Mentorship Program has been implemented at the UWI campuses in Jamaica and the Bahamas.

Now through the Strategic Alliance, we look forward to working with CGCS on additional collaborative initiatives for the benefit of women’s cancer control in the Caribbean.

Malaysia
Please join us in welcoming 43 new members from the Malaysian Gynecological Cancer Society ( MGCS ) to the IGCS Strategic Alliance Partner Program. We would like to thank Dr. Vicknesh Visvalingam , Senior Consultant Gynecological Oncologist & MGCS President in securing our partnership.

Malaysia is a country in Southeast Asia with a population of over 33 million. Cervical, ovarian and uterine cancers are among the top 10 most common cancers among Malaysian women. Much has been achieved in improving gynecological oncology services in Malaysia in the past 50 years. There is a structured program under the purview of the Ministry of Health Malaysia to increase the number of gynecological oncologists in order to cope with the burden of gynecological cancers in the country.
In 2001, the first gynecologic oncology training center was established in the northern region of Malaysia and today there are 12 recognized hospitals providing training. Most major Malaysian hospitals currently have one or two trained gynecologic oncologists to serve the public. With the support from the Ministry of Health Malaysia, academic Institutions and the Obstetrics and Gynecology Society of Malaysia, MGCS has been involved in various training programs, conferences, workshops, and in training and educating the public.

MGCS organizes the Biennial National Gynaecological Oncology Conference and is also involved in preparing the Malaysian Clinical Practice Guidelines on site specific gynecological cancers as well as research projects. We look forward to working with MGCS in furthering our joint goals to improve women’s cancer care in Malaysia.

Peru
Finally, Dr. Aldo López Blanco and nurse Ninoska Eugenia Macavilca Luyo were instrumental in securing a partnership with the Instituto Nacional de Enfermedades Neoplasicas-Peru, bringing 44 gynecologic oncologists into the IGCS Strategic Alliance.

With a population of 32 million, Peru is located on the west coast of South America where one-third of the total population lives in Lima, the capital city. When it comes to cancer control, Peru has unique challenges because this concentration of population in only one city contributed to structural, infrastructural and procedural barriers for the Peruvian health system. Cervical and breast cancer are a leading cause of death among women in Peru.

The National Institute of Neoplastic Diseases, better known as INEN, is a Peruvian public hospital managed by the Ministry of Health of Peru that has a national responsibility for cancer prevention, detection, treatment, education, and research. The INEN has organized satellite treatment centers and cancer prevention offices in many parts of the country in an effort to decentralize cancer control services and reduce gaps in geographic and economic access.

In the past decade alone, much work has been done to mobilize policies and actions for the prevention and control of cancer in Peru though the commitment of INEN, the National Government of Peru’s Ministries of Health and Finance and through international collaborations with the global health community. IGCS looks forward to assisting our colleagues in Peru with their tireless efforts to reduce the incidence of gynecologic cancers in the region.

We are glad to welcome our most recent partners into the IGCS global community and look forward to collaborating and developing strategies to utilize our strengths to achieve our common goals.

Education Highlight: In the Know

This month’s IGCS Education Highlight is from In the Know – Ed’s List.

In the Know is prepared by Edward Pavlik, PhD, Professor and Director of Ovarian Screening Research Program, University of Kentucky on a monthly basis. Ed’s lists provide a compilation of abstracts related to the field of gynecologic oncology from multiple scholarly journals.

 

The following is an article chosen from Ed’s List: Development of Peritoneal Carcinoma in women diagnosed with Serous Tubal Intraepithelial Carcinoma (STIC) following Risk-Reducing Salpingo-Oophorectomy (RRSO). PI Stanciu, TE. J. Ind, DPJ. Barton, JB Butler, KM Vroobel, AD Attygalle, MAE Nobbenhuis. Journal of Ovarian Research 12(50) 2019

The article concludes:

Cases negative for evidence of serous carcinoma of peritoneal origin at the time of Risk-Reducing Salpingo-Oophorectomy and found to be STIC positive, developed serous carcinoma of peritoneal origin 4-6 years later. This suggests that continuing follow-up should be considered when a STIC lesion has been identified.

Stay “In the Know” and keep up with Ed’s List in the Members-Only IGCS Literature Library.

View the latest update from the IGCS Education Committee Chairs regarding content that can be found in the Education Portal and see what’s coming soon!

Drug Duo Granted Breakthrough Status to Treat Endometrial Cancer

August 2, 2018: Cure – The FDA has granted a breakthrough therapy designation to the combination of Lenvima (lenvatinib) and Keytruda (pembrolizumab) for the treatment of patients with advanced and/or metastatic non–microsatellite instability high (MSI-H)/proficient mismatch repair endometrial carcinoma who have progressed after at least one prior systemic therapy. Read more.